Annals of Surgical Oncology

, Volume 20, Issue 9, pp 3112–3119 | Cite as

Preoperative Classification of Pancreatic Cystic Neoplasms: The Clinical Significance of Diagnostic Inaccuracy

  • Clifford S. Cho
  • Andrew J. Russ
  • Agnes G. Loeffler
  • Robert J. Rettammel
  • Gregory Oudheusden
  • Emily R. Winslow
  • Sharon M. Weber
Pancreatic Tumors



The potential for malignant transformation varies among pancreatic cystic neoplasms (PCN) subtypes. Imaging and cyst fluid analysis are used to identify premalignant or malignant cases that should undergo operative resection, but the accuracy of operative decision-making process is unclear. The objective of this study was to characterize misdiagnoses of PCN and determine how often operations are undertaken for benign, non-premalignant disease.


A retrospective analysis of patients undergoing pancreatic resection for the preoperative diagnosis of PCN was undertaken. Preoperative and pathological diagnoses were compared to measure diagnostic accuracy.


Between 1999 and 2011, 74 patients underwent pancreatic resection for the preoperative diagnosis of PCN. Preoperative classification of mucinous vs. non-mucinous PCN was correct in 74 %. The specific preoperative PCN diagnosis was correct in 47 %, but half of incorrect preoperative diagnoses were clinically equivalent to the pathological diagnoses. The likelihood that the pathological diagnosis was of higher malignant potential than the preoperative diagnosis was 7 %. In 20 % of cases, the preoperative diagnosis was premalignant or malignant, but the pathological diagnosis was benign. Diagnostic accuracy and the rate of undercall diagnoses and overcall operations did not change with the use of EUS or during the time period of this analysis.


Precise, preoperative classification of PCN is frequently incorrect but results in appropriate clinical decision-making in three-quarters of cases. However, one in five pancreatic resections performed for PCN was for benign disease with no malignant potential. An appreciation for the rate of diagnostic inaccuracies should inform our operative management of PCN.





  1. 1.
    Gajoux S, Brennan MF, Gonen M, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011;212:590–600.CrossRefGoogle Scholar
  2. 2.
    Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRefGoogle Scholar
  3. 3.
    Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol. 2007;102:2339–49.PubMedCrossRefGoogle Scholar
  4. 4.
    Bose D, Tamm E, Liu J, et al. Multidisciplinary management strategy for incidental cystic lesions of the pancreas. J Am Coll Surg. 2010;211:205–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Leung KK, Ross WA, Evans D, et al. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol. 2009;16:2818–24.PubMedCrossRefGoogle Scholar
  6. 6.
    Donahue TR, Hines OJ, Farrell JJ, et al. Cystic neoplasms of the pancreas: results of 114 cases. Pancreas. 2010;39:1271–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Correa-Gallego C, Ferrone CR, Thayer SP, et al. Incidental pancreatic cysts: do we really know what we are watching? Pancreatology. 2010;10:144–50.PubMedCrossRefGoogle Scholar
  8. 8.
    Lewandrowski KB, Southern JF, Pins MR, et al. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann Surg. 1993;217:41–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Allen PJ, Jaques DP, D’Angelica M, et al. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003;7:970–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Ryu JK, Woo SM, Hwang JH, et al. Cyst fluid analysis for the differential diagnosis of pancreatic cysts. Diagn Cytopathol. 2004;31:100–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Brugge WR, Lweandrowski K, Lee-Lewandrowski E, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126:1330–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasm of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–85.PubMedCrossRefGoogle Scholar
  13. 13.
    Sahani DV, Kadavigere R, Saokar A, et al. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics. 2005;25:1471–84.PubMedCrossRefGoogle Scholar
  14. 14.
    van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc. 2005;62:383–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;246:571–9.CrossRefGoogle Scholar
  16. 16.
    Jang JY, Kim SW, Lee SE, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg. Oncol. 2008;15:199–205.PubMedCrossRefGoogle Scholar
  17. 17.
    Ceppa EP, De la Fuente SG, Reddy SK, et al. Defining criteria for selective operative management of pancreatic cystic lesions: does size really matter? J Gastrointest Surg. 2010;14:236–44.PubMedCrossRefGoogle Scholar
  18. 18.
    Cizniger S, Turner B, Bilge AR, et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas. 2011;40:1024–8.CrossRefGoogle Scholar
  19. 19.
    Procacci C, Biasiutti C, Carbognin G, et al. Characterization of cystic tumors of the pancreas: CT accuracy. J Comput Assist Tomogr. 1999;23:906–12.PubMedCrossRefGoogle Scholar
  20. 20.
    Curry CA, Eng J, Horton K, et al. CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? AJR Am J Roentgenol. 2000;175:99–103.PubMedCrossRefGoogle Scholar
  21. 21.
    Ahmad NA, Kochman ML, Bernsinger C, et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc. 2003;58:59–64.PubMedCrossRefGoogle Scholar
  22. 22.
    Allen PJ, D’Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006;244:572–82.PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2013

Authors and Affiliations

  • Clifford S. Cho
    • 1
    • 2
  • Andrew J. Russ
    • 1
  • Agnes G. Loeffler
    • 3
  • Robert J. Rettammel
    • 1
  • Gregory Oudheusden
    • 1
  • Emily R. Winslow
    • 1
  • Sharon M. Weber
    • 1
    • 2
  1. 1.Section of Surgical OncologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Surgical ServiceWilliam S. Middleton Memorial VA HospitalMadisonUSA
  3. 3.Department of PathologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations